Lockheed Martin Corp. (LMT - Free Report) has received a contract to provide foreign military sales production support for Joint Air-to-Surface Standoff Missile (JASSM). Work related to the deal will be executed in Orlando, FL.
Valued at $99 million, the contract was awarded by the Air Force Life Cycle Management Center, Eglin Air Force Base, Florida. Per the terms of the agreement, Lockheed Martin will provide lifecycle support for all efforts related to JASSM and any JASSM variants in the areas of system upgrades, integration, production, sustainment, management and logistical support.
The contract is scheduled to be completed by August 2024 and will serve the nations of Finland, Poland and Australia.
A Brief Note on JASSM
The JASSM is a long range, conventional, stealthy, air-launched ground attack cruise missile designed for the Air Force and international partners with a range of 223-621.4 miles. JASSM was designed to destroy high-value, well-defended, fixed and re-locatable targets. The threshold integration aircraft were the F-16, B-52, and F/A-18 E/F.
The airframe design was to be compatible with all intended JASSM launch platforms — the B-52H, F-16C/D, F/A-18E/F, F-15E, F-117, B-1B, B-2, P-3C and S-3B.
What’s Favoring Lockheed Martin?
Increasing geopolitical and socioeconomic turmoil worldwide has prompted nations, both developed and developing, to expand the respective military arsenal with missiles constituting a significant portion of that inventory.
As one of the major missile makers in the United States, Lockheed Martin stands out among its peers by virtue of its broadly-diversified programs and strong order bookings. In second-quarter 2019, revenues at its Missiles and Fire Control unit came in at $2.41 billion, increasing 16% year over year, driven by higher sales for the tactical and strike missiles programs plus the sensors and global sustainment programs. At the end of the second quarter, this segment has a solid backlog of $26.2 billion.
The global rocket and missile market, which also includes fleet ballistic missiles, is projected to witness a CAGR of 4.74% during the 2017-2022 period to reach a value of $70 billion by 2022 (as per Markets and Markets research firm).
Such projections reflect increased growth opportunities for major missile-players like Lockheed Martin, Raytheon (RTN - Free Report) , Northrop Grumman (NOC - Free Report) and Boeing (BA - Free Report) in the aforementioned market.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>